Sympathetic Augmentation in Hypertension
Markus P. Schlaich(The University of Western Australia), Murray Esler(Baker Heart and Diabetes Institute), Duncan J. Campbell(St. Vincent's Birmingham), Jacqui Hastings(St Vincents Institute of Medical Research), Zygmunt S. Krozowski(The Heart Research Institute), Gavin Lambert(Swinburne University of Technology), David M. Kaye(Alfred Health), Anuradha Aggarwal(Friedrich-Alexander-Universität Erlangen-Nürnberg), Élisabeth Lambert(Swinburne University of Technology)
Cited by 512
Related Papers
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
|The Lancet|2010|2.2k
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
|The Lancet|2009|2.1k
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.
|Circulation|1986|1k
Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions
|Physiological Reviews|1990|792
Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension
|New England Journal of Medicine|2009|774